Patent ID: 9346886
Filing Date: 2016-05-24
CPC Classification: A61P,C07K

Claim Text:
1. A method for treating a patient suffering from a CDCP1 expressing cancer, said method comprising administering to a patient diagnosed as having such a disease an effective amount of a pharmaceutical composition comprising an antibody which specifically binds to human CDCP1 comprising: (a) a variable heavy chain domain (VH) of SEQ ID NO:3, or (b) a variable light chain domain (VL) of SEQ ID NO:14, SEQ ID NO:15, SEQ ID NO:16, SEQ ID NO:17, SEQ ID NO:18, SEQ ID NO:19, SEQ ID NO:20, SEQ ID NO:21, SEQ ID NO:22, SEQ ID NO:23, or SEQ ID NO:24.